Ginkgo Bioworks
DNAKey Statistics
Open
$9.40
Day High
$9.75
Day Low
$9.10
Prev. Close
$9.46
VolumeShares traded today.
1.14M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$583.98M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-1.70
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$17.58
52W LowLowest price over the past 52 weeks.
$5.37
50D MAAverage closing price over the last 50 trading days.
$7.82
200D MAAverage closing price over the last 200 trading days.
$9.65
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+16.0%1M
+24.9%6M
+7.6%YTD
+7.7%1Y
+34.8%About
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.
Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade DNA
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.